MustGrow Biologics Corp.
MGRO.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -97.32% | 631.92% | 179.92% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -97.32% | 631.92% | 179.92% | -- | -- |
| Cost of Revenue | 149.64% | 491.40% | 693.10% | 4,036.00% | 366.67% |
| Gross Profit | -23.57% | -44.57% | -52.52% | 809.65% | -366.67% |
| SG&A Expenses | -23.56% | 44.71% | 25.70% | 83.84% | 11.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.84% | 83.68% | 58.55% | 347.13% | -6.13% |
| Operating Income | 16.19% | -22.98% | -37.85% | -4.75% | 6.13% |
| Income Before Tax | 34.20% | -73.74% | -43.13% | -12.16% | -24.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.20% | -73.74% | -43.13% | -12.16% | -24.11% |
| Earnings from Discontinued Operations | -70.16% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.77% | -73.74% | -43.13% | -12.16% | -48.95% |
| EBIT | 16.19% | -22.98% | -37.85% | -4.75% | 6.13% |
| EBITDA | 16.37% | -- | -- | -- | -- |
| EPS Basic | 30.63% | -52.38% | -34.73% | -11.03% | -50.00% |
| Normalized Basic EPS | 45.22% | 0.95% | -35.57% | -10.59% | -23.66% |
| EPS Diluted | 30.63% | -52.38% | -34.73% | -11.03% | -50.00% |
| Normalized Diluted EPS | 45.22% | 0.95% | -35.57% | -10.59% | -23.66% |
| Average Basic Shares Outstanding | 20.07% | 14.06% | 5.94% | 0.94% | -0.28% |
| Average Diluted Shares Outstanding | 20.07% | 14.06% | 5.94% | 0.94% | -0.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |